Skip to main content

Table 1 Clinical, anthropometric and laboratory characteristics of studied groups

From: Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome

  Control group (mean ± SD)
(n = 120)
PCO patients (mean ± SD)
(n = 180)
P
Age (years) 31.38 ± 7.88 31.95 ± 7.42 0.527
Systolic blood pressure (mm Hg) 127.6 ± 5.62 131.06 ± 7.021 <0.001*
Diastolic blood pressure (mm Hg) 86.2 ± 3.94 87.31 ± 6.074 0.076
Hirsutism score 5.53 ± 0.472 13.54 ± 2.51 <0.001*
Body mass index (kg/m2) 30.28 ± 57 31.889.99 0.103
Waist/hip ratio 1.11 ± 0.26 1.14 ± 0.30 0.392
FMI (kg/m2) 7.66 ± 1.45 7.86 ± 1.579 0.260
FFMI (kg/m2) 21.81 ± 4.13 22.42 ± 4.47 0.233
Ovarian volume 4.33 ± 1.1 10.64 ± 1.3 <0.001*
AFC 5.33 ± 1.1 12.14 ± 1.4 <0.001*
Total cholesterol (mg/dL) 179.47 ± 19.7 198.8 ± 52.38 <0.001*
Triglycerides (mg/dL) 150.23 ± 20.84 187.6 ± 62.14 <0.001*
LDL cholesterol (mg/dL) 117.48 ± 19.05 165.98 ± 60.15 <0.001*
HDL cholesterol (mg/dL) 56.58 ± 6.04 39.2 ± 13.63 <0.001*
Fasting plasma glucose (mg/dL) 87.65 ± 9.14 108.2 ± 21.62 <0.001*
2-h plasma glucose (mg/dL) 127.6 ± 24.2 163.67 ± 41.7 <0.001*
HbA1c (%) 5.82 ± 0.182 6.35 ± 0.977 <0.001*
Fasting serum insulin (lU/mL) 7.14 ± 1.427 20.05 ± 7.3 <0.001*
HOMA-IR 1.55 ± 0.39 4.63 ± 1.87 <0.001*
HOMA-β 169.7 ± 18.14 122.01 ± 43.6 <0.001*
FSH (mIU/mL) 6.17 ± 1.53 6.6 ± 1.26 <0.001*
LH (mIU/mL) 6.95 ± 0.646 10.3 ± 1.23 <0.001*
LH/FSH 1.24 ± 0.54 1.6 ± 0.278 <0.001*
SHBG (nmol/L) 53.58 ± 6.04 28.8 ± 4.71 <0.001*
DHEA-S (mg/mL) 1.22 ± 0.33 2.37 ± 0.316 <0.001*
Androstenedione (ng/mL) 1.41 ± 0.508 1.62 ± 0.557 <0.001*
Total testosterone (ng/mL) 0.67 ± 0.18 1.1 ± 0.218 <0.001*
Free androgen index 1.03 ± 0.36 2.56 ± 1.22 <0.001*
hs-CRP (μg/ml) 2.61 ± 0.51 5.56 ± 0.98 <0.001*
WBC count (cell×103/μl) 4.74 ± 0.397 6.97 ± 2.31 <0.001*
CIMT (mm) 0.69 ± 0.06 1.18 ± 0.46 <0.001*
Serum ICAM-1 (ng/ml) 87.8 ± 49.5 445.17 ± 184.95 <0.001*
Relative ICAM expression levels 0.75 ± 0.48 4.57 ± 2.16 <0.001*
  1. FSI fasting serum insulin, FPG fasting plasma glucose, AFC antral follicle cells, FMI fat mass index, FFMI fat free mass index, HOMA-IR homeostasis model assessments of insulin resistance, DHEA dehydroepiandrosterone;. *P < 0.05 when compared with control group